FDA’s New China Director Looks To Strengthen CFDA Ties
This article was originally published in PharmAsia News
Executive Summary
August saw a change in the US FDA’s point person for China, as long-term FDA China director Chris Hickey left for a positon with Pfizer and Leigh Verbois took the charge with a mission to further develop strong ties with the China FDA amid the Chinese regulator’s hectic efforts to jumpstart regulatory reforms.